Business
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US
PHILADELPHIA, June 16, 2025--GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and lupus nephritis (LN).
About this update from Gsk Plc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/b9be818fd98f9210f3f3bb4227e4a0f9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YTd4i1bfbFv8qR0ktEiBxg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b9be818fd98f9210f3f3bb4227e4a0f9","width":480,"height":480}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Grant funding will be provided to support national, state, and local non-profit organizations and community-based groups focused on lupus","length":137,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"New resources and tools will support implementation of community-led programs designed to improve earlier diagnosis, enhance awareness of and access to evidence-based treatment, and/or advance communication between patients and providers","length":237,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Deadline for proposals is September 1, 2025","length":43,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":417,"olType":false},{"type":"text","content":"PHILADELPHIA, June 16, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and lupus nephritis (LN).","length":267,"tagName":"p"},{"type":"text","content":""Too many people living with lupus face delays in diagnosis and disconnects in care," said Court Horncastle, Senior Vice President at GSK. "With this initiative, we’re proud to support the organizations working within local communities to improve diagnosis, access to optimal care, and connection for those impacted by lupus."","length":346,"tagName":"p"},{"type":"text","content":"GSK is seeking proposals for community-driven initiatives aimed at improving earlier diagnosis and recognition of lupus signs and symptoms; enhancing awareness of and access to evidence-based treatment options; and/or advancing communication between patients and providers regarding lupus.","length":289,"tagName":"p"},{"type":"text","content":"GSK is committing up to $1 million USD in grant fund...